CITIM 2009

- 130+ participants

- 26 countries represented

- Five Travel Award selected from submitted abstracts

- Fifteen Short Talks selected from submitted abstracts

- CITIM 2009 was reviewed in the J. Immunotoxicology, Future Oncology, and in the Targeted Proteins database developed by Current BioDataLtd (www.currentbiodata.com). Brief conference review was also published by Thomson Reuters Scientific Division, Thomson Pharma (www.thomson-pharma.com) and Thomson Pharma Partnering (previously the IDdb; www.partnering.thomson-pharma.com

- Selected presentations from CITIM 2009 participants were published in the Journal of Immunotoxicology

- An outstanding sightseeing tour during the Conference and 3-day trip to Odessa and other cities after the meeting

- Many new friendships, collaborations, and student exchange.

- CITIM primary organizers:

• Michael R. Shurin, University of Pittsburgh, Pittsburgh, PA, USA (Center)
• Viktor Umansky, German Cancer Research Center, Heidelberg, Germany (Left)
• Anatoli M. Malyguine, NCI-Frederick, Frederick, MD, USA (Right).

CITIM 2011

 

- 170+ participants

- 28 countries represented

- Five Travel Award selected from submitted abstracts

- Fifteen Short Talks selected from submitted abstracts

- CITIM 2011 was reviewed in the J. Immunotoxicology, Cancer Immunology and Immunotherapy (CII), and Immunotherapy.

- Selected presentations from CITIM 2011 participants were published in the Journal of Immunotoxicology and Cancer Immunology and Immunotherapy (CII)

- An outstanding sightseeing tour during the Conference and a 3-day trip to different Hungarian cities after the meeting.